These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28306152)

  • 1. Assessment of Ex Vivo Transport Function in Isolated Rodent Brain Capillaries.
    Chan GNY; Cannon RE
    Curr Protoc Pharmacol; 2017 Mar; 76():7.16.1-7.16.16. PubMed ID: 28306152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurement of blood-brain barrier permeability.
    Boje KM
    Curr Protoc Pharmacol; 2002 Aug; Chapter 7():Unit 7.4. PubMed ID: 22294082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.
    Miller DS; Bauer B; Hartz AM
    Pharmacol Rev; 2008 Jun; 60(2):196-209. PubMed ID: 18560012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier].
    Terasaki T
    Yakugaku Zasshi; 2021; 141(4):447-462. PubMed ID: 33790111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essentials and Perspectives of Computational Modelling Assistance for CNS-oriented Nanoparticle-based Drug Delivery Systems.
    Kisała J; Hęclik KI; Pogocki K; Pogocki D
    Curr Med Chem; 2018; 25(42):5894-5913. PubMed ID: 29768999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to brain by microparticulate systems.
    Kaş HS
    Adv Exp Med Biol; 2004; 553():221-30. PubMed ID: 15503459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.
    Sjöstedt N; Kortejärvi H; Kidron H; Vellonen KS; Urtti A; Yliperttula M
    Pharm Res; 2014 Jan; 31(1):1-19. PubMed ID: 23797466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
    Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
    Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal expression of transporters and receptors in a rat primary co-culture blood-brain barrier model.
    Liu H; Li Y; Lu S; Wu Y; Sahi J
    Xenobiotica; 2014 Oct; 44(10):941-51. PubMed ID: 24827375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABC of the blood-brain barrier - regulation of drug efflux pumps.
    Mahringer A; Ott M; Reimold I; Reichel V; Fricker G
    Curr Pharm Des; 2011; 17(26):2762-70. PubMed ID: 21827407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
    Abdul Razzak R; Florence GJ; Gunn-Moore FJ
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
    Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental methods and transport models for drug delivery across the blood-brain barrier.
    Fu BM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1346-59. PubMed ID: 22201587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biology of the blood-brain barrier: Part I].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2009 Nov; 165(11):863-74. PubMed ID: 19427009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.